Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Find out which cards give the best cash back rewards to ensure you are maximizing your benefits on everyday spending.
26,220 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Investors are watching Micron Technology closely as AI-driven demand reshapes memory markets. This guide explains whe...
Oracle is slated to post Q3 results after the market closes, with a 5:00 p.m. ET conference call. Here’s what to watc...
Adobe posted solid quarterly results but faces mounting downgrades as analysts question AI monetization, pricing powe...
Duolingo stock crashing has sparked a flurry of headlines. This guide breaks down the causes, what it means for the b...
With an average $70,000 salary in the crosshairs, this explainer shows the math and the risks behind replacing work i...
Soccer's biggest tournament is moving to North America in 2026 with an expanded field and a booming betting market. T...
A new Medicare bridge program could lower GLP-1 drug bills to about $50 a month for eligible seniors. Here’s what you...
Cathie Wood is back in the IPO spotlight. This piece breaks down the three newly public names Ark Invest reportedly a...
A surge in 2024 five-percent CDs is quietly lifting Medicare premiums in 2026 through IRMAA, due to income reported t...
Workday posted a solid Q4 beat on earnings and revenue, yet forward guidance disappointed investors. Shares tumbled a...
When a k-pop star left group, it isn’t just a headline. It sets off a wave of spending, policy shifts, and career rei...